Enrico Buonamico

Bari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Real-life preliminary evidence for basophils as predictors of Tezepelumab response in severe asthma.

Real-life preliminary evidence for basophils as predictors of Tezepelumab response in severe asthma.

Journal: Expert review of clinical immunology

Published: June 05, 2025

Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study.

Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study.

Journal: Journal of clinical medicine

Published: September 09, 2024

Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the "Silent Zone" to Achieving "Quiet Asthma".

Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the "Silent Zone" to Achieving "Quiet Asthma".

Journal: Journal of clinical medicine

Published: March 01, 2024

Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development?

Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development?

Journal: Respiratory medicine

Published: December 10, 2023

The Predictors of Long COVID in Southeastern Italy.

The Predictors of Long COVID in Southeastern Italy.

Journal: Journal of clinical medicine

Published: August 25, 2023

Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.

Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.

Journal: ERJ open research

Published: June 26, 2023

Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience.

Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience.

Journal: Respiratory medicine

Published: April 15, 2023

Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.

Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.

Journal: Frontiers in immunology

Published: April 12, 2023

Asthma and Fixed Airways Obstruction: Real Life Aspects.

Asthma and Fixed Airways Obstruction: Real Life Aspects.

Journal: Advances in respiratory medicine

Published: December 21, 2022

A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation.

A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation.

Journal: Expert review of respiratory medicine

Published: September 28, 2022

The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit.

The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit.

Journal: Respiratory medicine

Published: August 18, 2022

Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study.

Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study.

Journal: Acta bio-medica : Atenei Parmensis

Published: July 22, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026